Point/Counterpoint: Combined Adcomm Briefing Document Not A Collaboration, US FDA Says

 
• By Sue Sutter
  
Separation
New guidance on joint briefing documents for ODAC meetings emphasizes the concept of separate contributions from the sponsor and agency. (Shutterstock)

More from US Advisory Committees

More from Product Reviews